NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model

scientific article

NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1021178108
P356DOI10.1038/APS.2009.83
P932PMC publication ID4006662
P698PubMed publication ID19575001
P5875ResearchGate publication ID26338508

P50authorJing ZhangQ60322603
P2093author name stringJin-Fu Xu
Peng Xu
Hong-Ni Jiang
Jie-Ming Qu
Hui-Jun Zhang
P2860cites workSystemic Fungal Infections Caused by Aspergillus Species: Epidemiology, Infection Process and Virulence DeterminantsQ22305789
Aspergillus fumigatus: principles of pathogenesis and host defenseQ24681995
Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcomeQ24811601
Aspergillus fumigatus and aspergillosisQ29617908
Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants.Q33754922
Ginkgo biloba extract (EGb 761) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxideQ33787874
The pathobiology of Aspergillus fumigatusQ34341968
A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in miceQ34488549
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patientsQ34630182
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary diseaseQ35745445
Current approaches to diagnosis and treatment of invasive aspergillosisQ36357893
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatusQ36482511
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosisQ36489697
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavusQ37226618
Efficacy of amphotericin B or itraconazole in a murine model of central nervous system Aspergillus infectionQ39740590
Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophagesQ40016783
TLRs govern neutrophil activity in aspergillosisQ40483206
Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosisQ40734608
N-acetylcysteine: pharmacological considerations and experimental and clinical applications.Q40916404
Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patientsQ41998776
Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyteQ43187504
Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling siteQ43802798
Effects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophagesQ44209179
Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosisQ44548714
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafunginQ44583938
The effect of antioxidant treatment in pneumonia of granulocytopenic ratsQ45213168
Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock.Q45941435
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosisQ46729762
A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.Q54424829
Cytokine profiling of pulmonary aspergillosis.Q54588391
Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.Q54626435
Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in miceQ59413542
[Pathogenicity of various species of Candida in mice immunodepressed with cyclophosphamide]Q70612913
Effect of amphotericin B lipid formulation on immune response in aspergillosisQ73098476
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosisQ79829012
Invasive aspergillosis in critically ill patients without malignancyQ80269940
Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patientQ80891404
Role of collectins in innate immunity against aspergillosisQ81094937
Th1/Th2 in aspergillosisQ92928837
Aspergillosis in the ICU - The new 21st century problem?Q92929057
P433issue7
P921main subjectaspergillosisQ259626
pulmonary injuryQ7259546
invasive pulmonary aspergillosisQ54946623
P304page(s)980-986
P577publication date2009-07-01
P1433published inActa Pharmacologica SinicaQ15749885
P1476titleNAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model
P478volume30

Reverse relations

cites work (P2860)
Q34367333Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice
Q40138687Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.
Q34336393Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice
Q40688557In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents

Search more.